Merck Sharp and Dohme

Type
Business expansion
Country
Ireland
Region
Ireland; Southern; South-East
Location of affected unit(s)
Carlow
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
170 jobs
Number of planned job creations
Job creation
Announcement Date
3 November 2008
Employment effect (start)
Foreseen end date
30 November 2011

Description

US-owned pharmaceuticals company Merck Sharp and Dohme (MSD) has announced the creation of 170 new jobs at a new vaccine facility plant to be based in Carlow. The new high skilled posts are to include experts in science, engineering, pharmacy, microbiology, technology, IT, and management and recruitment will commence in 2009 and will be completed in 2011. 300 jobs will also be generated, possibly divided among several companies, in the construction phase. MSD currently employs 530 people in Ireland.

Sources

  • 4 November 2008: The Irish Examiner

Citation

Eurofound (2008), Merck Sharp and Dohme, Business expansion in Ireland, factsheet number 67328, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/67328.